SUBSCRIBE
SUBSCRIBE

Fibrobiologics

IN THE PRESS
Press Releases
FibroBiologics to Present at the DealFlow Discovery Conference
January 20, 2026
 · 
1 min read
Press Releases
FibroBiologics CEO Issues Letter to Shareholders
January 8, 2026
 · 
8 min read
Press Releases
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
January 6, 2026
 · 
1 min read
Press Releases
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
January 5, 2026
 · 
6 min read
Press Releases
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
January 1, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 17, 2025
 · 
5 min read
Press Releases
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 16, 2025
 · 
5 min read
Press Releases
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
December 11, 2025
 · 
4 min read
Press Releases
FibroBiologics Announces Payoff of Outstanding Debt
November 27, 2025
 · 
4 min read
Press Releases
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 26, 2025
 · 
5 min read
Load More
JOBS